Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001164 · ClinicalTrials.gov registry record

Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status

NCT00001164: Completed study, sponsored by National Cancer Institute (NCI).

NCT00001164 is a clinical trial that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001164 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status

Study Summary

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

Trial Details

FieldValue
Start Date 1978-07
Est. Completion 2000-06

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00001164

The ClinicalTrials.gov registry entry for NCT00001164 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001164 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001164 about?

NCT00001164 is a clinical study titled "Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers". It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of ...

What is the current status of trial NCT00001164?

This trial is currently completed. The study started on 1978-07. Estimated completion is 2000-06.

Who is sponsoring clinical trial NCT00001164?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.